삼성서울병원

Ko En

Pulmonary and Critical Care Medicine Chung, Man Pyo M.D

Expertise
interstitial lung disease, pulmonary fibrosis
Treament Schedule 09 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM
Treament Schedule 10 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
THU
31
AM
PM

Medical Education

1995 Ph.D. in Medicine Seoul National University, Korea
1990 Master of Science Seoul National University, Korea
1986 Seoul National University College of Medicine, Korea

Post-Graduate Training

Fellowship   1993~1994 Division of Pulmonology, Seoul National University Hospital, Korea
Residency   1987~1990 Department of Medicine, Seoul National University Hospital, Korea
Internship   1986~1987 Seoul National University Hospital, Korea

Professional Appointments

2007~Present Professor Department of Medicine, Sungkyunkwan University School of Medicine
1994~Present Staff Division of Pulmonary and critical care medicine, Samsung Medical Center
2009~2015 Chair Division of Pulmonary and critical care medicine, Samsung Medical Center
2001~2007 Associate Professor Department of Medicine, Sungkyunkwan University School of Medicine
2000~2002 Postdoctoral Research Fellow University of Iowa, USA
1997~2001 Assistant Professor Department of Medicine, Sungkyunkwan University School of Medicine

Professional Memberships

Member of Korean Society of Tuberculosis and Pulmonary Disease
Member of Korean Medical Association
Active member of American Thoracic Society
Active member of American College of Chest Physicians

Selected Publications

  • ANN AM THORAC SOC 2021 10.1513/AnnalsATS.202005-451OC Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis A Nationwide Cohort Study Moon1, SW; Kim, SY; Chung, MP; Yoo, H; Jeong, SH; Kim, DS; Song, JW; Lee, HL; Choi, SM; Kim, YW; Kim, YH; Park, CS; Park, SW; Park, JS; Jegal, Y; Lee, J; Uh, ST; Kim, TH; Lee, JH; Kim, YH; Shin, B; Lee, HK; Yang, SH; Lee, H; Kim, SH; Lee, EJ; Choi, HS; Shin, H; Park, YB; Shin, JW; Park, MS
    View PubMed
  • ADV THER 2020 10.1007/s12325-020-01328-8 Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients Chung1, MP; Park, MS; Oh, IJ; Lee, HB; Kim, YW; Park, JS; Uh, ST; Kim, YS; Jegal, Y; Song, JW
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759 Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY
    View PubMed
  • BMC PULMONARY MEDICINE 2019 10.1186/s12890-019-0905-8 Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study Yoo1, H; Jeong, BH; Chung, MJ; Lee, KS; Kwon, OJ; Chung, MP
    View PubMed
  • INT J TUBERC LUNG D 2019 10.5588/ijtld.18.0194 Clinical features and prognosis of patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Lee1, SH; Park, JS; Kim, SY; Kim, DS; Kim, YW; Chung, MP; Uh, ST; Park, CS; Park, SW; Jeong, SH; Park, YB; Lee, HL; Shin, JW; Lee, JH; Jegal, Y; Lee, HK; Kim, YH; Song, JW; Park, MS
    View PubMed